Efficacy and Safety of 6-Month Nightly Ramelteon Administration in Adults with Chronic Primary Insomnia

2009145 citationsJournal Articlebronze Open Access

Authors

Geert Mayer · Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde

GeertSherry Wang-Weigand · Takeda (Japan)

Barbara F. Roth‐Schechter

R. Lehmann · Gesellschaft für Klinische Forschung

Corinne Staner · Centre hospitalier de Rouffach

Markku Partinen · University of Helsinki

Abstract

In adults with chronic insomnia, long-term ramelteon treatment consistently reduced sleep onset, with no next-morning residual effects or rebound insomnia or withdrawal symptoms upon discontinuation.

Topics & Keywords

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: SLEEP

Volume 32, Issue 3, pp. 351-360

DOI: 10.1093/sleep/32.3.351

Field-Weighted Citation Impact: 14.24